HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.

Abstract
Pheochromocytomas occur sporadically and are associated with several dominantly inherited cancer syndromes, including von Hippel-Lindau (VHL) disease. We examined 14 pheochromocytomas (four from VHL patients, nine from sporadic patients, and one from a patient with familial pheochromocytoma) for loss of heterozygosity on chromosome arm 3p by using the polymerase chain reaction and restriction fragment length polymorphisms at eight loci. Loss of heterozygosity was detected in 8 of 14 pheochromocytomas examined: in three of the four VHL-associated tumors, in four of the nine sporadic tumors, and in the familial pheochromocytoma-associated tumor. Deletion of the inherited wild-type VHL allele was demonstrated in both informative VHL-associated pheochromocytomas, demonstrating involvement of VHL in pheochromocytoma development. However, because VHL mutations have not been detected in sporadic pheochromocytomas, VHL and/or another chromosome arm 3p gene may be involved in the etiology of these tumors.
AuthorsM A Zeiger, B Zbar, H Keiser, W M Linehan, J R Gnarra
JournalGenes, chromosomes & cancer (Genes Chromosomes Cancer) Vol. 13 Issue 3 Pg. 151-6 (Jul 1995) ISSN: 1045-2257 [Print] United States
PMID7669733 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Adrenal Gland Neoplasms (complications, genetics)
  • Chromosomes, Human, Pair 3
  • DNA, Neoplasm (analysis)
  • Heterozygote
  • Humans
  • Pheochromocytoma (complications, genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • von Hippel-Lindau Disease (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: